Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes [13]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 3, 2007, Pages 638-639

  Sauls, D L ^a   Banini, A E ^b   Boyd, L C ^b   Hoffman, Maureane ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FIBRINOGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ASSAY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GRAPE JUICE; HUMAN; INSULIN BLOOD LEVEL; INTERNATIONAL NORMALIZED RATIO; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTHROMBIN TIME; RISK FACTOR; SEX DIFFERENCE; THROMBOSIS; BLOOD; BLOOD CLOTTING; METABOLISM;

BLOOD COAGULATION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN; RISK FACTORS; THROMBOSIS;

EID: 34247554276     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02366.x     Document Type: Letter

References (10)

1. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med 1953; 41: 637-47.
2. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961; 36: 212-9.
3. Korte W, Clarke S, Lefkowitz JB. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Am J Clin Pathol 2000; 113: 123-7.
4. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104: 3631-4.
5. Hron G, Eichinger S, Weltermann A, Quehenberger P, Halbmayer WM, Kyrle PA. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 2006; 4: 752-6.
6. Tripodi A, Mannucci PM. Activated partial thromboplastin time (aptt). New indications for an old test? J Thromb Haemost 2006; 4: 750-1.
7. Bertina RM. The prothrombin 20210 g to a variation and thrombosis. Curr Opin Hematol 1998; 5: 339-42.
8. Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: A possible mechanism of the increased thrombotic risk. Blood 2003; 101: 3008-13.
9. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR. Metabolic syndrome and diabetic atherothrombosis: Implications in vascular complications. Curr Mol Med 2006; 6: 501-14.
10. Banini AE, Boyd LC, Allen JC, Allen HG, Sauls DL. Muscadine grape products intake, diet and blood constituents of non-diabetic and Type 2 diabetic subjects. Nutrition 2006; 22: 1137-45.